GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Net Margin %

G.Barekat Pharm (XTEH:BRKT1) Net Margin % : 5.05% (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. G.Barekat Pharm's Net Income for the six months ended in Mar. 2017 was IRR1,044,706 Mil. G.Barekat Pharm's Revenue for the six months ended in Mar. 2017 was IRR20,679,266 Mil. Therefore, G.Barekat Pharm's net margin for the quarter that ended in Mar. 2017 was 5.05%.

The historical rank and industry rank for G.Barekat Pharm's Net Margin % or its related term are showing as below:


XTEH:BRKT1's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.67
* Ranked among companies with meaningful Net Margin % only.

G.Barekat Pharm Net Margin % Historical Data

The historical data trend for G.Barekat Pharm's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Net Margin % Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Net Margin %
3.58 5.05

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Net Margin % 3.58 5.05

Competitive Comparison of G.Barekat Pharm's Net Margin %

For the Biotechnology subindustry, G.Barekat Pharm's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Net Margin % distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Net Margin % falls into.



G.Barekat Pharm Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

G.Barekat Pharm's Net Margin for the fiscal year that ended in Mar. 2017 is calculated as

Net Margin=Net Income (A: Mar. 2017 )/Revenue (A: Mar. 2017 )
=1044706/20679266
=5.05 %

G.Barekat Pharm's Net Margin for the quarter that ended in Mar. 2017 is calculated as

Net Margin=Net Income (Q: Mar. 2017 )/Revenue (Q: Mar. 2017 )
=1044706/20679266
=5.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm  (XTEH:BRKT1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


G.Barekat Pharm Net Margin % Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines